CasLoc logo
All Cases PTAB Litigations UPC Oppositions

ViiV Healthcare Company v. Mylan Inc.

1:12-cv-01065

Overview

Case Number 1:12-cv-01065
Filing Date 2012-08-22
Status Terminated
Termination Date 2014-07-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Mylan Pharmaceuticals Inc. Operating Company

Represented By

5 Attorneys Listed

Christopher G. Wilson

Email: chwilson@wsgr.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Matthew R. Reed

Email: MReed@wsgr.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Mylan Inc. Operating Company

Represented By

10 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Wendy L. Devine

Email: wdevine@wsgr.com

Randal Miller

Email: rmiller@wsgr.com

Nancy L. Zhang

Email: nancyzhang@quinnemanuel.com

Matthew R. Reed

Email: MReed@wsgr.com

Elham F. Steiner

Email: esteiner@wsgr.com

Douglas H. Carsten

Email: dcarsten@mwe.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Plaintiff

Vertex Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

ViiV Healthcare Company NPE (Individual / Inventor)

Represented By

6 Attorneys Listed

Richard J. McCormick

Email: rmccormick@mayerbrown.com

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Lisa M. Ferri

Email: lferri@mayerbrown.com

Jonathan H. Kim

Email: jkim@mayerbrown.com

Brian W. Nolan

Email: bnolan@mayerbrown.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Counter Defendant

Viiv Healthcare UK Limited NPE (University / Research)

Represented By

1 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 25 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (25): 🇨🇦 Canada CN 🇩🇪 Germany 🇪🇺 Europe 🇯🇵 Japan KR 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6436989
Prodrugs of aspartyl protease inhibitors
Filed: 1997-12-24
Issued: 2002-08-20
Expired (Term Ended)
Expires: 2017-12-24

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

34

Dispositive

7

Granted

2

Denied

2

Pending / Review

18

Motions by Category

Claim Construction / Markman Filing 4 Procedural / Extension Motion 18 Motion to Stay Pending IPR / Reexam 7 Motion to Stay 5

Key Dispositive Motions & Rulings

Motion to Stay Pending IPR / Reexam Denied
ORDER Denying 47 MOTION to Stay Pending Completion of Inter Partes Review, and Denying as Moot 49 Conditional Cross Motion to Stay. The parties are to report to...
Entry #59 • 2013-09-17 Document →
Motion to Stay Pending IPR / Reexam Pending
ORAL ORDER: The Court will hear oral argument on the MOTION to Stay Pending Completion of Inter Partes Review (D.I. 47 ), and the Conditional Cross Motion to St...
Entry #— • 2013-06-18
Motion to Stay Pending IPR / Reexam Pending / Under Review
REQUEST for Oral Argument by Mylan Inc., Mylan Pharmaceuticals Inc. re 49 Conditional Cross Motion to Stay, 47 MOTION to Stay Pending Completion of Inter Partes...
Entry #55 • 2013-06-10 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
REPLY BRIEF re 49 Conditional Cross Motion to Stay, 47 MOTION to Stay Pending Completion of Inter Partes Review filed by Vertex Pharmaceuticals Inc., ViiV Healt...
Entry #52 • 2013-05-31 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
BRIEF (Combined Opening and Answering) re 49 Conditional Cross Motion to Stay, and 47 MOTION to Stay Pending Completion of Inter Partes Review, filed by Mylan I...
Entry #50 • 2013-05-20 Document →
Motion to Stay Pending IPR / Reexam Pending
Remark: Set Answering Brief Deadline re 47 MOTION to Stay Pending Completion of Inter Partes Review. Answering Brief/Response due date per Local Rules is 5/20/2...
Entry #— • 2013-05-06

Docket Entries

(173 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGMENT - filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350.00, receipt number 0311-1127306.) - filed by ViiV Healthcare Company, Vertex Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(rwc) (Entered: 08/23/2012)

Entry #1 • 2012-08-22
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 08/23/2012)

Entry #2 • 2012-08-22
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/11/12. Date of Expiration of Patent: 6/24/18.Thirty Month Stay Deadline: 1/11/2015. (rwc) (Entered: 08/23/2012)

Entry #3 • 2012-08-22
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,436,989 B1. (rwc) (Entered: 08/23/2012)

Entry #4 • 2012-08-22
1

Summons Issued with Magistrate Consent Notice attached as to Mylan Inc. on 8/23/2012; Mylan Pharmaceuticals Inc. on 8/23/2012. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc)

Entry #5 • 2012-08-23
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc